Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Non-Interventional Observational Study on Patient Satisfaction With the Benepali Pre-Filled Pen

Trial Profile

Non-Interventional Observational Study on Patient Satisfaction With the Benepali Pre-Filled Pen

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2018

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis
  • Focus Therapeutic Use
  • Sponsors Biogen
  • Most Recent Events

    • 22 Oct 2018 Status changed from recruiting to completed.
    • 16 Jun 2018 Interim analysis results (as of Nov 2017, n=142) assessing patient satisfaction with Etanercept biosimilar (Sb4) pre-filled pen among rheumatoid arthritis and spondyloarthropathy patients, presented at the 19th Annual Congress of the European League Against Rheumatism.
    • 19 Dec 2017 Planned End Date changed from 31 Dec 2017 to 31 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top